Molecular subtypes are prognostic for N3 breast cancer patients in the modern therapeutic era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular subtypes are prognostic for N3 breast cancer patients in the modern therapeutic era

Published:2018-11-19 Issue: Volume: Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:mol clin onc

Author:

Yersal �zlem¹,Kaplan Muhammed²,Işikdoğan Abdurrahman²,�zdemir Nuriye³,Aliustaoğlu Mehmet⁴,Barutca Sabri¹,Erdoğdu Halil⁵,Meydan Nezih¹

Affiliation:

1. Department of Medical Oncology, Adnan Menderes University Faculty of Medicine, Aydin 09010, Turkey

2. Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir 21280, Turkey

3. Department of Medical Oncology, Numune Training and Research Hospital, Ankara 06230, Turkey

4. Department of Medical Oncology, Dr L�tfi Kirdar Kartal Training and Research Hospital, İstanbul 34865, Turkey

5. Department of Pathology, Adnan Menderes University Faculty of Medicine, Aydin 09010, Turkey

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nontherapeutic Risk Factors of Different Grouped Stage IIIC Breast Cancer Patients’ Mortality: A Study of the US Surveillance, Epidemiology, and End Results Database;The Breast Journal;2022-08-30

Clinical Outcomes of N3 Breast Cancer: A Real-World Study of a Single Institution and the US Surveillance, Epidemiology, and End Results (SEER) Database

;Cancer Management and Research;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP